Publications by authors named "Fu-Shun Ko"
LX9211, a rising star for relieving of diabetic peripheral neuropathic pain.
J Diabetes Investig
November 2024
Article Synopsis
- - LX9211 showed significant pain reduction in diabetic peripheral neuropathy (DPN) patients during a multicenter trial, with noticeable relief reported by the first week at a 10 mg dose.
- - Higher doses of LX9211 were less effective, but side effects like dizziness and nausea were mostly mild.
- - The results underscore the need to investigate both drug-based and natural treatment options, like flavonoids, for managing DPN.
Aim: To assess the likelihood of dementia in individuals with type 2 diabetes (T2D), distinguishing between those with and without microvascular diseases.
Methods: Leveraging the National Health Insurance Research Database in Taiwan, we identified individuals newly diagnosed with T2D from 1 January 2009 through 31 December 2014. Multivariable Cox proportional hazard models were used to compare the risk of outcomes.